Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic trial of RHB 105 in healthy volunteers

Trial Profile

Pharmacokinetic trial of RHB 105 in healthy volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 07 Apr 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amoxicillin/omeprazole/rifabutin (Primary) ; Amoxicillin; Omeprazole; Rifabutin
  • Indications Gastrointestinal disorders; Helicobacter pylori infections
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors RedHill Biopharma
  • Most Recent Events

    • 07 Apr 2014 New trial record
    • 23 Dec 2013 RedHill Biopharma has indicated that the results from this trial were positive; however, the data were subject to a final analysis and were to be reported at a later date.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top